Drug
(+)-pseudoephedrine sulfate clinical trials
A product of Pseudoephedrine; its studies count on that page too.
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
5 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2010 | 1 |
| 2018 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Bayer (3) · Ranbaxy Laboratories Limited (1) · Azidus Brasil (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses (+)-pseudoephedrine sulfate is read from its arms, and is right about nine times in ten.
Testing it · 5
- Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic RhinitisWithdrawnPhase 3Azidus BrasilNCT01055756Written as Loratadine + Pseudoephedrine sulfate
- A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen ExposureCompletedPhase 4BayerNCT03443843Written as loratadine + pseudoephedrine sulfate (BAY818725/Claritin-D)
- A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult SubjectsCompletedPhase 1BayerNCT03517930Written as Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG)
- A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult SubjectsCompletedPhase 1BayerNCT03517943Written as Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG)
- Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed ConditionsCompletedNot applicableRanbaxy Laboratories LimitedNCT00845546Written as 10 mg Loratadine/240 mg Pseudoephedrine Sulfate Extended-Release Tablets
Codes
What other systems call (+)-pseudoephedrine sulfate · ClinicalTrials.gg INT018574
- UNII (FDA) Y9DL7QPE6BPSEUDOEPHEDRINE SULFATEConfirmed FDA, Wikidata
- RxNorm 91169Confirmed FDA, Wikidata
- Wikidata Q27294410(+)-pseudoephedrine sulfateConfirmed FDA, Wikidata
- NCI Thesaurus C47696Pseudoephedrine SulfateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | Y9DL7QPE6B | PSEUDOEPHEDRINE SULFATE | Confirmed FDA, Wikidata |
| RxNorm | 91169 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27294410 | (+)-pseudoephedrine sulfate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C47696 | Pseudoephedrine Sulfate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.